Literature DB >> 32654822

Intracytoplasmic sperm injection (ICSI) for non-male factor indications: a committee opinion.

.   

Abstract

Intracytoplasmic sperm injection, while typically effective for overcoming low or absent fertilization in couples with a clear abnormality of semen parameters, is frequently used in combination with assisted reproductive technologies for other etiologies of infertility in the presence of semen parameters that meet the World Health Organization 2010 normative reference values. This committee opinion provides a critical review of the literature, where available, to identify situations where this may or may not be of benefit. This document replaces the previously published document of the same name, last published in 2012 (Fertil Steril 2012;98:1395-9).
Copyright © 2020 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 32654822     DOI: 10.1016/j.fertnstert.2020.05.032

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  19 in total

1.  Pre-IVF treatment with a GnRH antagonist in women with endometriosis (PREGNANT): study protocol for a prospective, double-blind, placebo-controlled trial.

Authors:  Hugh Taylor; Howard J Li; Sandra Carson; Valerie Flores; Lubna Pal; Jared Robbins; Nanette F Santoro; James H Segars; David Seifer; Hao Huang; Steven Young; Heping Zhang
Journal:  BMJ Open       Date:  2022-06-17       Impact factor: 3.006

2.  Assisted reproductive technology cycles involving male factor infertility in the United States, 2017-2018: data from the National Assisted Reproductive Technology Surveillance System.

Authors:  Amy Jewett; Lee Warner; Jennifer F Kawwass; Akanksha Mehta; Michael L Eisenberg; Ajay K Nangia; James M Dupree; Stanton Honig; James M Hotaling; Dmitry M Kissin
Journal:  F S Rep       Date:  2022-03-25

3.  Placental histology and pregnancy complications following intracytoplasmic sperm injection for non-male factor infertility.

Authors:  Hadas Ganer Herman; Alexander Volodarsky-Perel; Tuyet Nhung Ton Nu; Alexandre Machado-Gedeon; Yiming Cui; Jonathan Shaul; Michael H Dahan
Journal:  J Assist Reprod Genet       Date:  2022-03-21       Impact factor: 3.357

4.  Calcium chloride dihydrate supplementation at ICSI improves fertilization and pregnancy rates in patients with previous low fertilization: a retrospective paired treatment cycle study.

Authors:  Mark P Green; Deirdre Zander-Fox; Sophie Popkiss; Fabrizzio Horta; Beverley Vollenhoven
Journal:  J Assist Reprod Genet       Date:  2022-03-09       Impact factor: 3.357

5.  Machine-learning algorithm incorporating capacitated sperm intracellular pH predicts conventional in vitro fertilization success in normospermic patients.

Authors:  Stephanie Jean Gunderson; Lis Carmen Puga Molina; Nicholas Spies; Paula Ania Balestrini; Mariano Gabriel Buffone; Emily Susan Jungheim; Joan Riley; Celia Maria Santi
Journal:  Fertil Steril       Date:  2021-01-15       Impact factor: 7.490

6.  Differences in ICSI utilization rates among states with insurance mandates for ART coverage.

Authors:  Pavel Zagadailov; Kyung S Cho; David B Seifer
Journal:  Reprod Biol Endocrinol       Date:  2021-11-30       Impact factor: 5.211

7.  Effect of early rescue ICSI and split IVF-ICSI in preventing low fertilization rate during the first ART cycle: A real-world retrospective cohort study.

Authors:  Linlin Jiang; Yifan Qian; Xiaoli Chen; Xiaohui Ji; Songbang Ou; Ruiqi Li; Dongzi Yang; Yu Li
Journal:  Reprod Med Biol       Date:  2021-10-27

8.  Disrupting the biological clock: Fertility benefits, egg freezing and proactive fertility management.

Authors:  Lucy van de Wiel
Journal:  Reprod Biomed Soc Online       Date:  2021-12-10

9.  In vitro fertilisation (IVF) versus intracytoplasmic sperm injection (ICSI) in patients without severe male factor infertility: study protocol for the randomised, controlled, multicentre trial INVICSI.

Authors:  Sine Berntsen; Bugge Nøhr; Marie Louise Grøndahl; Morten Rønn Petersen; Lars Franch Andersen; Anne Lis Englund; Ulla Breth Knudsen; Lisbeth Prætorius; Anne Zedeler; Henriette Svarre Nielsen; Anja Pinborg; Nina La Cour Freiesleben
Journal:  BMJ Open       Date:  2021-06-24       Impact factor: 2.692

Review 10.  Advances in the Treatment and Prevention of Chemotherapy-Induced Ovarian Toxicity.

Authors:  Hyun-Woong Cho; Sanghoon Lee; Kyung-Jin Min; Jin Hwa Hong; Jae Yun Song; Jae Kwan Lee; Nak Woo Lee; Tak Kim
Journal:  Int J Mol Sci       Date:  2020-10-21       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.